Assessment of Integrated Classifier's Ability to Distinguish Benign From Malignant Lung Nodules: Extended Analyses and 2-Year Follow-Up Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial

Chest. 2021 Mar;159(3):1283-1287. doi: 10.1016/j.chest.2020.10.069. Epub 2020 Nov 7.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Aged
  • Area Under Curve
  • Diagnosis, Differential
  • Female
  • Follow-Up Studies
  • Humans
  • Lung / diagnostic imaging
  • Lung / pathology
  • Lung Neoplasms* / diagnosis
  • Lung Neoplasms* / pathology
  • Male
  • Multiple Pulmonary Nodules* / diagnostic imaging
  • Multiple Pulmonary Nodules* / pathology
  • Neoplasms
  • Proteomics / methods*
  • Risk Factors
  • Smoking / epidemiology
  • Solitary Pulmonary Nodule* / diagnostic imaging
  • Solitary Pulmonary Nodule* / pathology
  • Tomography, X-Ray Computed / methods*
  • Tumor Burden